Expand New Drugs for TB [endTB]

CompletedOBSERVATIONAL
Enrollment

2,804

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

December 30, 2019

Conditions
Tuberculosis, Multidrug-Resistant
Interventions
OTHER

This is a non-intervention observational study

No applicable intervention; this is a secondary data analysis observational study.

Trial Locations (16)

220053

Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk

Unknown

National Treatment Centre for Tuberculosis, Abovian, Armenia, Abovyan

National Institute of Diseases of the Chest and Hospital (NIDCH), Dhaka, Dhaka

Aung San Tuberculosis Hospital, Yangon

Bishoftu Hospital, Bishoftu

RS Islam Jakarta Cempaka Putih, Jakarta

MSF Tuberculosis clinic, Mathare, Nairobi, Kenya, Nairobi

Kara-Suu District TB hospital, Kara Suu

Botshabelo Hospital, Maseru

The Indus Hospital, Karachi, Karachi

Institute of Chest Diseases, Kotri, Kotri

Gulab Devi Chest Hospital, Lahore, Lahore

Socios en Salud, Carabayllo

King Dinuzulu Hospital, Durban

0101

National Center for Tuberculosis and Lung Diseases, Tbilisi

050010

National Research Center for Phthisionpulmonology, Almaty

All Listed Sponsors
collaborator

Médecins Sans Frontières, France

OTHER

collaborator

Interactive Research and Development

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

Epicentre

OTHER

lead

Partners in Health

OTHER